University of Iowa Health Care researchers have received an $18 million grant to study a brain disorder that mostly affects young women during their childbearing years.
The disease is called idiopathic intracranial hypertension, or IIH. IIH occurs when the pressure of the fluid that...
The Department of Ophthalmology and Visual Sciences has received an unrestricted grant from Research to Prevent Blindness (RPB) in the amount of $115,000 per year for five years. The funding was awarded based on a thorough review of...
A Gene Therapy Update from the Department of Ophthalmology and Visual Sciences Carver College of Medicine, and Institute for Vision Research at the University of Iowa
The pharmaceutical company Spark Therapeutics recently announced FDA approval [1,2] of a gene therapy known as Luxturna...
Department chair Keith D. Carter, M.D., FACS began his term as the 122nd president of the American Academy of Ophthalmology (AAO) on January 1. Dr. Carter was elected to the position by the Academy’s community of ophthalmologists in recognition of his scientific leadership, international...
Several alumni, faculty, and former faculty from the University of Iowa were recognized in 2017 for their significant achievements in ophthalmology and retina subspecialty. Each individual listed is a Charter Inductee of the Retina Hall of Fame.
- Gary Abrams, MD (ʻ78F)
-...
Survey results are in! Ophthalmology Times , a specialty publication for ophthalmologists, resumed its “Best Programs Survey” after a several year break and recently released the 2017 results.
Ophthalmology department chairmen and residency program directors across the U.S. were surveyed...
Michael D. Abramoff, MD, PhD , The Robert C. Watzke, MD, Professor of Retina Research, Professor of Ophthalmology and Visual Sciences, participated in two Congressional briefings on Wednesday, October 25, to show how research spurs the economy....
Dr. H. Culver Boldt, professor of ophthalmology and director of the Ocular Echography service, was selected as the 2017 Clinician of the Year by the University of Iowa Physicians (UIP). The award recognizes a clinician who most embodies those aspects of a truly great patient service provider,...
Dr. Stephen Russell, along with other doctors, patients and parents, presented results from a Phase 3 clinical trial to a Food and Drug Administration (FDA) advisory panel. The panel sought to evaluate a treatment developed by Spark Therapeutics and known as voretigene neparvovec for...